Inhibiting BMAA from Access to Decrease the Risk of Having Neurodegenerative Diseases
DOI:
https://doi.org/10.61173/6fxrv382Keywords:
BMAA, algae, PP2A, Tau protein, Western-blot therapyAbstract
Purpose: Neurodegenerative diseases are commonly seen in groups that have greater age. Although the exact pathway of Alzheimer’s is still unclear, the amino acid BMAA that Nostoc algae have fixed was predicted to inhibit PP2A proteins and cause Hyperphosphorylation on tau proteins and lead to tau protein tangle, which is the known agent that causes Alzheimer’s. So, the paper is dedicated to inhibiting BMAA from inhibiting PP2A kinases and seeing whether it can control the rate of neurodegenerative diseases’ appearance.